SRZN
Surrozen, Inc.NASDAQHealthcare$27.87-1.69%ClosedMarket Cap: $208.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.09
P/S
58.92
EV/EBITDA
-1.19
DCF Value
$11.41
FCF Yield
-14.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.7%
Operating Margin
-1210.6%
Net Margin
-6960.8%
ROE
610.8%
ROA
-245.1%
ROIC
-46.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $528.0K | 91.5% | $-12.6M | $-183.2M | $-23.87 | — |
| FY 2025 | $3.5M | 84.6% | $-42.1M | $-242.0M | $-32.37 | — |
| Q3 2025 | $983.0K | 100.0% | $-10.9M | $-71.6M | $-8.36 | — |
| Q2 2025 | $983.0K | 100.0% | $-9.0M | $39.7M | $2.55 | — |
| Q1 2025 | $983.0K | 100.0% | $-9.6M | $-27.0M | $-7.43 | — |
| Q4 2024 | $655.0K | 100.0% | $-8.6M | $-28.0M | $-9.00 | — |
| FY 2024 | $10.7M | 100.0% | $-25.5M | $-63.6M | $-21.67 | — |
| Q3 2024 | $10.0M | 100.0% | $1.2M | $-1.4M | $-0.44 | — |
| Q2 2024 | $0.00 | -Infinity% | $-9.0M | $-25.3M | $-7.99 | — |
| Q1 2024 | $0.00 | NaN% | $-9.1M | $-8.8M | $-4.24 | — |
| Q4 2023 | $0.00 | NaN% | $-9.7M | $-8.9M | $-4.32 | — |
| FY 2023 | $0.00 | -Infinity% | $-45.8M | $-43.0M | $-21.33 | — |